stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. DMTRF
    stockgist
    HomeTop MoversCompaniesConcepts
    DMTRF logo

    3-D Matrix, Ltd.

    DMTRF
    OTC
    Healthcare
    Medical - Devices
    Tokyo, JP106 employees3d-matrix.co.jp
    —

    At A Glance

    1

    3-D Matrix, Ltd.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees106
    Fundamentals

    How The Business Makes Money

    3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

    Industry Medical - Devices
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    HNSBFHansa Biopharma AB (publ)————
    CMVLFCellectis S.A.————
    AONCAmerican Oncology Network...————
    IDGXFIntegrated Diagnostics Ho...————
    MAYNFMayne Pharma Group Limite...————
    ABTIAlterola Biotech, Inc.————
    TRGNFTransgene S.A.————
    EAPIFEuroapi S.A.————
    Analyst View
    Company Profile
    CIKUNKNOWN_DMTRF
    ISINJP3410730000
    Phone81 3 3511 3440
    AddressKojimachi HF Building, Tokyo, 102-0083, JP
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice